Tumors Metastatic to Brain Active Not Recruiting Phase 2 Trials for Ipilimumab (DB06186)

IndicationStatusPhase
DBCOND0029875 (Tumors Metastatic to Brain)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02107755Stereotactic Radiation Therapy and Ipilimumab in Treating Patients With Metastatic MelanomaTreatment